home.aspx

 
.

APPLYING TECHNOLOGY TO NEW SCIENCE: BIOPHARMA’S NEW GROWTH ENGINE

SHARESHARESHARE
Today, there are clear signs that the biopharmaceutical industry is facing a quiet yet potentially damaging force: compressive disruption.  However, future-focused biopharma companies have found a way to deliver exceptional growth amidst compressive disruption: by embracing New Science, an ever-evolving combination of the best in science and health technology that is filling unmet need and raising the standard of care.  Accenture research finds that leaders in New Science are investing 6-7x more in digital, data and genomics compared to their peers.